ANGELA FRAUMANE: Open Payments
NPI 1821762410 · AMSTERDAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 53 payments from 15 companies in 2025. Trend: 2023 $66 · 2024 $978 · 2025 $1,230
Food & beverage: $1,230
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $294 |
| AstraZeneca Pharmaceuticals LP | 8 | $154 |
| Lilly USA, LLC | 6 | $125 |
| Novo Nordisk Inc | 4 | $89 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $86 |
| Axsome Therapeutics, Inc. | 1 | $82 |
| Lundbeck LLC | 3 | $81 |
| PFIZER INC. | 3 | $71 |
| Amgen Inc. | 3 | $63 |
| Tandem Diabetes Care, Inc. | 1 | $53 |
Products named: VRAYLAR, AIRSUPRA, Auvelity, MOUNJARO, REXULTI, QULIPTA, Rybelsus, NURTEC ODT.
Industry payments across NY — which companies pay providers there.
